Private label growth drives Creightons revenue increase in FY25

Creightons plc reported a significant financial turnaround for the year ended March 31, 2025, achieving a £2.5 million profit after tax, a notable reversal from the prior year's loss, driven by a 129.6% surge in operating profit to £3.5 million and a 57.9% increase in EBITDA to £5.1 million. The company's revenue grew 1.6% to £54.1 million, primarily fueled by strong private label sales and improved gross margins of 44.7% (up 180 bps), while operational efficiencies reduced distribution costs. Creightons also strengthened its net cash position to £3.0 million and strategically transitioned to the AIM market for reduced compliance costs.

Analysis

Creightons plc (CRGT) has demonstrated a significant financial turnaround for the fiscal year ended March 31, 2025, shifting from a £3.5 million loss in the prior year to a £2.5 million profit after tax. This recovery was not driven by substantial top-line growth, as revenue increased by a modest 1.6% to £54.1 million, but rather by significant operational improvements and a strategic shift in its sales mix. The company's gross margin expanded by 180 basis points to 44.7%, and operating profit before exceptional items surged 129.6% to £3.5 million. These gains were supported by a 20.8% reduction in distribution costs, achieved through logistics consolidation. A key driver of performance was the growth in private label sales to £29.2 million, which successfully offset declines in the branded products and contract manufacturing divisions. The company's financial health is further reinforced by an increased net cash position of £3.0 million and the board's proposal to raise the final dividend to 0.50 pence, signaling confidence in sustained performance. The recent transition to the AIM market is a strategic move aimed at reducing compliance costs and increasing regulatory flexibility.

Key Decisions for Investors

• The strong operational leverage, evidenced by a 129.6% increase in operating profit on minimal revenue growth, suggests the company's cost-control and efficiency measures are highly effective, warranting a positive reassessment of its earnings potential.
• Investors should closely monitor the continuing shift in revenue mix, as sustained growth in the private label segment is critical to offsetting the persistent decline in branded and contract manufacturing sales.
• The increased dividend and strengthened net cash position provide a basis for confidence, however, the recent move to the AIM market introduces factors of lower regulatory oversight and potentially reduced liquidity that must be considered.
• Future performance should be scrutinized to determine if this margin expansion and profitability are sustainable or represent a one-time recovery from the prior year's impairment-driven loss.